Recombinant Bovine VEGF-B Protein, N-His

Vascular Endothelial Growth Factor B (VEGF-B) is a member of the VEGF family known for its crucial role in mediating angiogenesis, the formation of new blood vessels from pre-existing ones, and for supporting the survival of endothelial cells. Unlike its better-studied counterparts, VEGF-A and VEGF-C, which are primarily involved in promoting blood vessel formation and lymphangiogenesis, VEGF-B has garnered attention for its unique functions in regulating metabolic processes and neuronal protection. Research indicates that VEGF-B plays a significant role in cardiovascular health, as it is involved in the development and maintenance of the cardiac and vascular systems. Furthermore, studies have suggested that VEGF-B may influence lipid metabolism and facilitate the delivery of fatty acids to tissues, highlighting its potential implications in metabolic disorders and diseases such as obesity and diabetes. Given its diverse biological functions, the recombinant protein form of VEGF-B has been explored as a therapeutic agent with promising applications in tissue engineering and regenerative medicine. Researchers are increasingly focused on elucidating the mechanisms of VEGF-B signaling pathways and its interactions with other growth factors, aiming to harness its potential for innovative treatments in vascular-related diseases and enhancing the efficacy of existing therapies. Understanding the nuanced role of VEGF-B in both normal physiology and disease states is critical for developing targeted strategies to manipulate angiogenic processes and improve outcomes in various clinical conditions.